Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jay L. Warner"'
Publikováno v:
Diabetes. 69
This post-hoc analysis explores whether high treatment satisfaction seen with a 3-day wearable patch for mealtime insulin subcutaneous delivery is applicable across different patient groups. The randomized multi-country study of adults (n=278, age: 5
Publikováno v:
Journal of Health Economics and Outcomes Research
Background: As type 2 diabetes (T2D) progresses, administering basal and bolus insulin through multiple daily injections (MDI) is often required to achieve target control, although many people fail to achieve target levels. Continuous subcutaneous in
Publikováno v:
Diabetes. 67
Continuous subcutaneous insulin infusion (CSII) in T2DM improves HbA1c and reduces insulin dosage vs. multiple daily injections (MDI). However, for T2DM traditional CSII can be costly and overly sophisticated. Emerging evidence shows T2DM can be trea